Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,075 | -1,554 | -837 | -615 | -23,629 |
| Depreciation Amortization | 172 | 343 | 287 | 154 | 938 |
| Accounts receivable | -128 | -105 | -219 | -54 | N/A |
| Accounts payable and accrued liabilities | 188 | 236 | 247 | 268 | 68 |
| Other Working Capital | 496 | 283 | 72 | 45 | -463 |
| Other Operating Activity | 1,112 | 916 | 858 | 195 | 22,068 |
| Operating Cash Flow | $-235 | $119 | $407 | $-7 | $-1,018 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -582 | -505 | -358 | -14 | -171 |
| Purchase Of Investment | -35 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-617 | $-505 | $-358 | $-14 | $-171 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 380 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -30 |
| Common Stock Issued | 1,098 | 43 | N/A | N/A | 1,380 |
| Financing Cash Flow | $1,098 | $423 | $N/A | $N/A | $1,350 |
| Beginning Cash Position | 173 | 173 | 173 | 173 | 12 |
| End Cash Position | 420 | 210 | 222 | 152 | 173 |
| Net Cash Flow | $247 | $37 | $49 | $-21 | $161 |
| Free Cash Flow | |||||
| Operating Cash Flow | -235 | 119 | 407 | -7 | -1,018 |
| Capital Expenditure | -582 | -505 | -358 | -14 | -171 |
| Free Cash Flow | -816 | -386 | 49 | -21 | -1,189 |